Karen Margrete Miller

Title: Karen Margrete Miller: Innovator in Pain Modulation

Introduction

Karen Margrete Miller is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pain modulation through her innovative research and development of pharmaceutical compositions. With a total of 6 patents to her name, Miller has established herself as a key figure in the biopharmaceutical industry.

Latest Patents

Miller's latest patents include groundbreaking work on a Na1.7 binding entity that functionally modifies the activity of the ion channel. This includes an anti-Na1.7 antibody or binding fragment, along with pharmaceutical compositions that comprise these antibodies. Her work focuses on the treatment and modulation of pain, detailing processes for generating and preparing these antibodies. Additionally, she has developed a method for treating patients for pain by administering an anti-ion channel antibody, specifically an anti-E1 ion channel antibody or binding fragment, which also includes pharmaceutical compositions for treatment.

Career Highlights

Throughout her career, Karen Margrete Miller has worked with notable companies such as UCB Pharma and UCB Biopharma Sprl. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective pain management solutions.

Collaborations

Miller has collaborated with esteemed colleagues, including Marc Roger De Ryck and Christian Gilbert J Wolff. These partnerships have further enriched her work and expanded the impact of her innovations in the field.

Conclusion

Karen Margrete Miller is a trailblazer in the realm of pain modulation, with a strong portfolio of patents and a commitment to advancing medical science. Her contributions continue to influence the development of effective treatments for pain management.